Abound Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20
Closed -$964 1546
2026
Q1
$964 Buy
+20
New +$933 ﹤0.01% 984
2024
Q4
Sell
-67
Closed -$3.86K 1330
2024
Q3
$3.86K Buy
+67
New +$3.62K ﹤0.01% 596
2024
Q1
Sell
-24
Closed -$1.19K 1388
2023
Q4
$1.19K Hold
24
﹤0.01% 741
2023
Q3
$1.29K Hold
24
﹤0.01% 677
2023
Q2
$1.29K Hold
24
﹤0.01% 703
2023
Q1
$1.31K Hold
24
﹤0.01% 623
2022
Q4
$1.16K Buy
+24
New +$1.05K ﹤0.01% 602

Other funds holding SNY

Abound Wealth Management's SNY Position: Q2 2026 in Review

Abound Wealth Management sold out of Sanofi (SNY) in Q2 2026, closing a stake of 20 shares — an estimated $964 sold.

Abound Wealth Management first reported a position in SNY in Q4 2022 and held it in 7 quarters. The position peaked at $3.86K in Q3 2024. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Abound Wealth Management reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Abound Wealth Management sold 20 Sanofi shares in Q2 2026, an estimated $964.
  • Abound Wealth Management first reported a position in Sanofi in Q4 2022 and held it in 7 quarters.
  • Abound Wealth Management's Sanofi position peaked at $3.86K in Q3 2024.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.